Prof Devi Sridhar is chair of global public health at the University of Edinburgh
attenuates in most patients as gastric adaptation occurs First-line management: Dietary sulfur load reduction, meal timing relative to injection day, and small-portion eating When to escalate: Persistent belching paired with regurgitation, significant dysphagia, or weight loss beyond expected therapeutic loss warrants GI evaluation When to discontinue: Sulfur burps alone are rarely grounds for stopping
Since then, Zepbound, the brand name for tirzepatide, has nearly become a household drug brand
Florida Medicaid coverage policy for Gastrointestinal Services explicitly references Bariatric Surgery revisions, reversals, or conversions for complications related to the surgery
Most side effects are mild and tend to diminish as the body adjusts to the medication
This combination has not been formally studied in clinical trials, but the biological rationale is sound based on what we know about both modalities